Bromide

Bromide

SCHEMBL6739425

Br.Br.Br.Br.Br.Br.Br.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1.CC1(C)CC(=O)CC(=O)C1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.45
ALOX15 P16050 1/20 0.45
MAOA P21397 1/20 0.42
MAPT P10636 5/20 0.40
KDM4E B2RXH2 3/20 0.37
POLB P06746 2/20 0.37
TSHR P16473 1/20 0.37
GAA P10253 5/20 0.36
HTT P42858 2/20 0.33
GLA P06280 1/20 0.33
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL16332561 1.00 ALDH1A1 (0.45) ALDH1A1ALOX15MAOAMAPTKDM4E
Bromide SCHEMBL7687601 1.00 ALDH1A1 (0.45) ALDH1A1ALOX15MAOAMAPTKDM4E
Bromide SCHEMBL6744490 1.00 ALDH1A1 (0.45) ALDH1A1ALOX15MAOAMAPTKDM4E
Bromide SCHEMBL16333039 1.00 ALDH1A1 (0.45) ALDH1A1ALOX15MAOAMAPTKDM4E
SCHEMBL9336430 0.97 ALDH1A1 (0.47) ALDH1A1ALOX15MAOAMAPTKDM4E
SCHEMBL123127 0.97 ALDH1A1 (0.47) ALDH1A1ALOX15MAOAMAPTKDM4E
Water SCHEMBL4753900 0.94 ALDH1A1 (0.45) ALDH1A1ALOX15MAOAMAPTKDM4E
SCHEMBL309527 0.94 ALDH1A1 (0.45) ALDH1A1ALOX15MAOAMAPTKDM4E
Iodide SCHEMBL2127044 0.94 ALDH1A1 (0.45) ALDH1A1ALOX15MAOAMAPTKDM4E
SCHEMBL9413781 0.94 ALDH1A1 (0.45) ALDH1A1ALOX15MAOAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559377-B2 Method of synthesizing a molecular sieve of MWW framework type EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-02-24 US claimed
US-20240101435-A1 Method of Synthesizing a Molecular Sieve of MWW Framework Type EXXONMOBIL CHEMICAL PATENTS INC. 2024-03-28 US claimed
EP-4301700-A1 METHOD OF SYNTHESIZING A MOLECULAR SIEVE OF MWW FRAMEWORK TYPE ExxonMobil Chemical Patents Inc. (US) 2024-01-10 EP claimed
US-20230264965-A1 Method of Synthesizing a Molecular Sieve of MWW Framework Type EXXONMOBIL CHEMICAL PATENTS INC. 2023-08-24 US claimed
EP-4182078-A1 METHOD OF SYNTHESIZING A MOLECULAR SIEVE OF MWW FRAMEWORK TYPE ExxonMobil Chemical Patents Inc. (US) 2023-05-24 EP claimed
WO-2022184759-A1 METHOD OF SYNTHESIZING A MOLECULAR SIEVE OF MWW FRAMEWORK TYPE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2022-09-09 WO claimed
WO-2022015491-A1 METHOD OF SYNTHESIZING A MOLECULAR SIEVE OF MWW FRAMEWORK TYPE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2022-01-20 WO claimed
US-12559377-B2 Method of synthesizing a molecular sieve of MWW framework type EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-02-24 US disclosed
US-20240101435-A1 Method of Synthesizing a Molecular Sieve of MWW Framework Type EXXONMOBIL CHEMICAL PATENTS INC. 2024-03-28 US disclosed
EP-4301700-A1 METHOD OF SYNTHESIZING A MOLECULAR SIEVE OF MWW FRAMEWORK TYPE ExxonMobil Chemical Patents Inc. (US) 2024-01-10 EP disclosed
US-20230264965-A1 Method of Synthesizing a Molecular Sieve of MWW Framework Type EXXONMOBIL CHEMICAL PATENTS INC. 2023-08-24 US disclosed
EP-4182078-A1 METHOD OF SYNTHESIZING A MOLECULAR SIEVE OF MWW FRAMEWORK TYPE ExxonMobil Chemical Patents Inc. (US) 2023-05-24 EP disclosed
WO-2022184759-A1 METHOD OF SYNTHESIZING A MOLECULAR SIEVE OF MWW FRAMEWORK TYPE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2022-09-09 WO disclosed
WO-2018060349-A1 CATALYST COMPRISING SMALL 10-RING ZEOLITE CRYSTALLITES AND A METHOD FOR PRODUCING HYDROCARBONS BY REACTION OF OXYGENATES OVER SAID CATALYST. HALDOR TOPSØE A/S (DK) 2018-04-05 WO disclosed
US-20150159048-A1 POLISHING COMPOSITION AND POLISHING METHOD ASAHI GLASS COMPANY, LIMITED (JP) 2015-06-11 US disclosed
US-20150159047-A1 POLISHING COMPOSITION AND POLISHING METHOD ASAHI GLASS COMPANY, LIMITED (JP) 2015-06-11 US disclosed
US-6692723-B2 MTT zeolite comprising crystals and crystal aggregates with specific granulometries, and its use as a catalyst for isomerizing straight chain paraffins INSTITUT FRANCAIS DU PETROLE (FR) 2004-02-17 US disclosed
US-6548040-B1 Isomerization catalyst for hydrocarbons INSTITUT FRANCAIS DU PETROLE (FR) 2003-04-15 US disclosed
US-20020192156-A1 MTT zeolite comprising crystals and crystal aggregates with specific granulometries, and its use as a catalyst for isomerising straight chain paraffins INSTITUT FRANCAIS DU PETROLE (FR) 2002-12-19 US disclosed
US-6475464-B1 Process for preparing a zeolite with structure type MTT using zeolitic material seeds INSTITUT FRANCAIS DU PETROLE (FR) 2002-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559377-B2 Method of synthesizing a molecular sieve of MWW framework type SIK1, SIK2, KCNK9 ALDH1A1 4759/4885ALOX15 4718/4885MAOA 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.